SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-236284
Filing Date
2020-08-31
Accepted
2020-08-31 16:36:05
Documents
17
Period of Report
2020-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d58964d8k.htm   iXBRL 8-K 39672
2 EX-10.1 d58964dex101.htm EX-10.1 33946
3 EX-10.2 d58964dex102.htm EX-10.2 34255
4 EX-10.3 d58964dex103.htm EX-10.3 28300
5 EX-10.4 d58964dex104.htm EX-10.4 6259
9 GRAPHIC g58964g67k62.jpg GRAPHIC 3281
  Complete submission text file 0001193125-20-236284.txt   307663

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kpti-20200825.xsd EX-101.SCH 3076
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20200825_lab.xml EX-101.LAB 18139
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20200825_pre.xml EX-101.PRE 11412
10 EXTRACTED XBRL INSTANCE DOCUMENT d58964d8k_htm.xml XML 3348
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 201151932
SIC: 2834 Pharmaceutical Preparations